| P2093 | author name string | Essex M | |
| | Rojko J | |
| | Trainin Z | |
| P2860 | cites work | Feline leukemia virus-induced thrombocytopenia and macrothrombocytosis in cats | Q33445261 |
| | In vitro activation of feline complement by feline leukemia virus | Q33905050 |
| | Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus | Q33913107 |
| | Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity | Q33969141 |
| | Naturally occurring persistent feline oncornavirus infections in the absence of disease | Q34115965 |
| | Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome | Q34186365 |
| | Passive immunity to feline leukemia: evaluation of immunity from dams naturally infected and experimentally vaccinated | Q34429123 |
| | Feline glucose-6-phosphate dehydrogenase cellular mosaicism. Application to the study of retrovirus-induced pure red cell aplasia | Q34523309 |
| | Molecular analysis of several classes of endogenous feline leukemia virus elements | Q35025850 |
| | Bvr-1, a restriction locus of a type C RNA virus in the feline cellular genome: identification, location, and phenotypic characterization in cat X mouse somatic cell hybrids | Q35044236 |
| | Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein | Q35053119 |
| | Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene | Q35605395 |
| | Characterization of a feline sarcoma virus-coded antigen (FOCMA-S) by radioimmunoassay | Q35991499 |
| | Appearance of cytotoxic antibody to viral gp70 on feline lymphoma cells (FL-74) in cats during ex vivo immunoadsorption therapy: quantitation, characterization, and association with remission of disease and disappearance of viremia | Q36270221 |
| | The U3 portion of feline leukemia virus DNA identifies horizontally acquired proviruses in leukemic cats | Q36384584 |
| | Protection against feline leukemia by vaccination with a subunit vaccine | Q36432298 |
| | Horizontally and Vertically Transmitted Oncornaviruses of Cats | Q36794005 |
| | Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma | Q36883883 |
| | Chromosomal position and specific demethylation in enhancer sequences of germ line-transmitted retroviral genomes during mouse development | Q36892642 |
| | Effects of cobra venom factor treatment on latent feline leukemia virus infection | Q36902354 |
| | Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias | Q45796657 |
| | Inhibition of erythroid colony-forming cells by a Mr 15,000 protein of feline leukemia virus | Q45796863 |
| | Erythrocyte Macrocytosis in Feline Leukemia Virus Associated Anemia | Q45797443 |
| | Inhibition of feline leukemia virus replication by human leukocyte interferon | Q45797677 |
| | Feline cytotoxic immune mechanisms against virus-associated leukemia and fibrosarcoma | Q45797798 |
| | Recovery of feline leukaemia virus from non-viraemic cats | Q45798356 |
| | Haemopoietic colony formation (BFU-E, GM-CFC) during the development of pure red cell hypoplasia induced in the cat by feline leukaemia virus | Q45798416 |
| | Role of suppressor cells in feline leukemia virus-associated immunosuppression | Q45798786 |
| | Similar transforming growth factors (TGFs) produced by cells transformed by different isolates of feline sarcoma virus | Q45799019 |
| | Neutralization of feline leukemia virus with feline antisera to leukocyte alloantigens | Q45799993 |
| | Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunosorption | Q45800396 |
| | Selective effect of feline leukaemia virus on early erythroid precursors. | Q45800680 |
| | Feline leukemia virus-induced erythroid aplasia: in vitro hemopoietic culture studies | Q45801109 |
| | A micro-enzyme-linked immunosorbent assay (ELISA) test for detection of feline leukemia virus in cats | Q45801423 |
| | Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection | Q45801498 |
| | Determinants of susceptibility and resistance to feline leukemia virus infection. I. Role of macrophages. | Q45801500 |
| | Development of virus non-producer lymphosarcomas in pet cats exposed to FeLV | Q45803009 |
| | Protection of Cats Against Feline Leukemia Virus-Positive and Virus-Negative Tumors by Complement-Dependent Antibody23 | Q45803664 |
| | Feline leukemia virus envelope gp70 of subgroups B and C defined by monoclonal antibodies with cytotoxic and neutralizing functions | Q45804607 |
| | Detection of circulating immune complexes by a Clq/protein A-ELISA during the preneoplastic stages of feline leukemia virus infection | Q45807102 |
| | Lymphosarcoma and persistent feline leukemia virus infection of pet cats: a system to study responses during extracorporeal treatments | Q45807800 |
| | A transmissible virus-induced lymphocytic leukemia of the cat | Q45809998 |
| | Feline leukemia-virus infection of kittens: mortality associated with atrophy of the thymus and lymphoid depletion. | Q45812369 |
| | Horizontal Transmission of Leukemia Virus and Leukemia in the Cat | Q45815065 |
| | Erythroid hypoplasia in cats inoculated with feline leukemia virus | Q45817952 |
| | Antibody response and virus survival in cats vaccinated against feline leukaemia | Q45818614 |
| | Early lesions in cats inoculated with feline leukemia virus. | Q45820114 |
| | Feline leukemia virus-associated enteritis--a condition with features of feline panleukopenia | Q45835229 |
| | Use of tears for diagnosis of feline leukemia virus infection. | Q45836771 |
| | Evaluation of terminal deoxynucleotidyl transferase expression in bone marrow of clinically normal and feline leukemia virus-exposed cats | Q45836998 |
| | Multilineage, non-species specific hematopoietic growth factor(s) elaborated by a feline fibroblast cell line: enhancement by virus infection | Q45837091 |
| | Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. | Q45837535 |
| | The nature of immunity to Snyder-Theilen fibrosarcoma virus induced tumors in cats | Q45838195 |
| | Killer cells of feline leukemia virus- and feline sarcoma virus-infected transformed cells: the role of NK, ADCC, and in vitro generated cytotoxic cells | Q45838308 |
| | Hypercalcemia in cats with feline-leukemia-virus-associated leukemia-lymphoma | Q45838473 |
| | The promoter of the long terminal repeat of feline leukemia virus is effective for expression of a mouse H-2 histocompatibility gene in mouse and human cells | Q45838633 |
| | Induction of protective immune response in cats by vaccination with feline leukemia virus iscom. | Q45838754 |
| | Antibody to feline oncornavirus-associated cell membrane antigen in neonatal cats | Q47732426 |
| | Feline Oncornavirus-Associated Cell Membrane Antigen. I. Serologie Studies With Kittens Exposed to Cell-Free Materials From Various Feline Fibrosarcomas2 | Q47956864 |
| | Retroviral transduction of T-cell antigen receptor beta-chain and myc genes | Q48348094 |
| | Conservation of the c-myc coding sequence in transduced feline v-myc genes | Q48358178 |
| | A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family | Q48366626 |
| | A guanine nucleotide-dependent phosphatidylinositol 4,5-diphosphate phospholipase C in cells transformed by the v-fms and v-fes oncogenes. | Q53537372 |
| | Stimulation of a cell-mediated cytotoxic response to FeLV-induced T cell lymphomas in the cat. | Q53542343 |
| | Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. | Q55244775 |
| | Transmissible Feline Fibrosarcoma | Q58973069 |
| | Expression of the c-fms proto-oncogene during human monocytic differentiation | Q59094172 |
| | Viral transduction of c-myc gene in naturally occurring feline leukaemias | Q59096775 |
| | Isolation of a feline leukaemia provirus containing the oncogene myc from a feline lymphosarcoma | Q59098646 |
| | Enucleation and the appearance of second primary tumors in cats bearing virally induced intraocular tumors | Q67235152 |
| | Effects of retrovirus protein on the feline one-way mixed leukocyte reaction | Q67278340 |
| | Suppression of the Humoral Antibody Response in Natural Retrovirus Infections | Q67289494 |
| | Experimental oncornavirus vaccines in the cat | Q67765646 |
| | Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests | Q68662758 |
| | Development and distribution of B lineage cells in the domestic cat: analysis with monoclonal antibodies to cat mu-, gamma-, kappa-, and lambda-chains and heterologous anti-alpha antibodies | Q69936542 |
| | Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion | Q70086465 |
| | The reversal of feline retroviral-induced suppression of lymphocyte Con A receptor mobility by indomethacin and PGE2 | Q70110775 |
| | Reversal of feline retroviral suppression by indomethacin | Q70119525 |
| | Feline leukemia vaccine: efficacy, contents and probable mechanism | Q70136300 |
| | The Hardy–Zuckerman 2-FeSV, a new feline retrovirus with oncogene homology to Abelson-MuLV | Q70150331 |
| | Demonstration of depressed polymorphonuclear leukocyte function in nonviremic FeLV-infected cats | Q70150415 |
| | Identification of calmodulin activity in purified retroviruses | Q70164692 |
| | The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70 | Q70182435 |
| | A feline thymocyte antigen defined by a monoclonal antibody (FT2) identifies a subpopulation of non-helper cells capable of specific cytotoxicity | Q70278206 |
| | Intranasal transmission of feline leukemia | Q70467135 |
| | Membranous Glomerulonephritis Associated with Leukaemia in Cats | Q70557110 |
| | Histocytology of lymphoid tumors in the dog, cat and cow | Q70849916 |
| | Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome | Q72790552 |
| | Circulating immune complexes associated with naturally occurring lymphosarcoma in pet cats | Q72869033 |
| | Natural killer activity against retrovirus infected cells: Dichotomy in NK sensitivity of infected T and B cells | Q72939636 |
| | A transmissible feline fibrosarcoma of viral origin | Q93828859 |
| | Reactivation of latent feline leukaemia virus infection | Q41553385 |
| | Recovery of soluble feline oncornavirus-associated cell membrane antigen from large volumes of tissue culture fluids | Q41568957 |
| | Characterization of feline glomerulonephritis associated with viral-induced hematopoietic neoplasms | Q42160161 |
| | Characterization of a newly established feline lymphoma-derived cell line (BKD) lacking T and B cell surface markers | Q42812668 |
| | Characterization of the expression of cellular retrovirus genes and oncogenes in feline cells | Q43501569 |
| | Feline oncornavirus-associated cell membrane antigen: A viral and not a cellularly coded transformation-specific antigen of cat lymphomas | Q43502458 |
| | Cyclic hematopoiesis associated with feline leukemia virus infection in two cats | Q43526685 |
| | Haemadsorption and haemagglutination by feline leukaemia viruses | Q43770338 |
| | Serum Erythropoietin Changes in Cats with Feline Leukemia Virus-induced Erythroid Aplasia | Q43778343 |
| | Ferrokinetic and erythrocyte survival studies in healthy and anemic cats | Q43989840 |
| | Feline leukemia virus: occurrence of viral antigen in the tissues of cats with lymphosarcoma and other diseases | Q44018387 |
| | Infectious feline leukaemia virus is erythrosuppressive in vitro | Q44121081 |
| | Horizontal transmission of feline leukaemia virus | Q44153916 |
| | Feline leukemia - unique and cross-relating antigens on individual virus-producing tumors identified by complement-dependent antibody | Q44207185 |
| | Suppression of gamma interferon production by inactivated feline leukemia virus | Q44282473 |
| | Naturally Occurring Retroviruses (RNA Tumor Viruses). II | Q44288795 |
| | Polymorphonuclear leukocyte dysfunction associated with feline leukaemia virus infection | Q44394494 |
| | Detection and prevalence of serotypes of feline syncytial spumaviruses | Q44736573 |
| | Flow cytometric and radioisotopic determinations of platelet survival time in normal cats and feline leukemia virus-infected cats | Q44752069 |
| | Mononuclear and polymorphonuclear leucocyte dysfunction in male homosexuals with the acquired immunodeficiency syndrome (AIDS). | Q45081093 |
| | Correlation between humoral antibody and regression of tumours induced by feline sarcoma virus | Q45223955 |
| | Effects of treatment with cobra venom factor on experimentally induced feline leukemia. | Q45348298 |
| | A VIRUS-LIKE PARTICLE ASSOCIATED WITH LEUKEMIA (LYMPHOSARCOMA). | Q45714534 |
| | Experimental anterior uveitis after subcutaneous injection of feline sarcoma virus | Q45793837 |
| | Cellular immune response in the blood of cats is restricted to autochthonous feline sarcoma virus-transformed cells | Q45793980 |
| | Characterization of monoclonal antibodies directed against the envelope proteins of feline leukemia virus | Q45796215 |
| | Infection with Feline Leukemia Virus Associated with Induction of Humoral Response to a Normal Cell Protein | Q45796411 |
| | Nucleotide sequence of a transduced myc gene from a defective feline leukemia provirus | Q36902841 |
| | Nucleotide Sequence of the Envelope Gene of Gardner-Arnstein Feline Leukemia Virus B Reveals Unique Sequence Homologies with a Murine Mink Cell Focus-Forming Virus | Q36932402 |
| | Feline leukemia virus: survival under home and laboratory conditions | Q37312760 |
| | Endogenous RD-114 virus genome expression in malignant tissues of domestic cats | Q37506794 |
| | Feline leukemia virus vaccines | Q39324286 |
| | Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus | Q39436064 |
| | Antibody response in cats to feline leukemia virus reverse transcriptase under natural conditions of exposure to the virus | Q39531029 |
| | Association of feline leukemia virus with lymphosarcoma and other disorders in the cat | Q39918335 |
| | Anemia Associated With Feline Leukemia Virus Infection in Cats 2 | Q39918803 |
| | Vaccination against feline leukaemia virus using a cell membrane antigen system | Q39952469 |
| | Immunosurveillance of naturally occurring feline leukemia | Q39965294 |
| | Biology of feline leukemia virus in the natural environment | Q39978270 |
| | Inactivation of tumor cell-associated feline oncornavirus for preparation of an infectious virus-free tumor cell immunogen | Q39989089 |
| | Immunization against feline oncarnavirus disease using a killed tumor cell vaccine | Q40006790 |
| | Prevention of the contagious spread of feline leukaemia virus and the development of leukaemia in pet cats | Q40010424 |
| | Feline Oncornavirus-Associated Cell Membrane Antigen. VI. Cytotoxic Antibody in Cats Exposed to Feline Leukemia Virus2 | Q40028101 |
| | Feline Leukemia Virus Infection: Age-Related Variation in Response of Cats to Experimental Infection2 | Q40034260 |
| | Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household | Q40039897 |
| | Feline Oncornavirus—Associated Cell Membrane Antigen: Expression in Transformed Nonproducer Mink Cells | Q40075735 |
| | Antibodies from healthy cats exposed to feline leukemia virus lyse feline lymphoma cells slowly with cat complement | Q40085139 |
| | Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats | Q40097861 |
| | Inhibition of normal lymphocyte mitogenic reactivity by serum from feline leukemia virus-infected cats | Q40097890 |
| | Immunopathology induced by the feline leukemia virus | Q40108318 |
| | Protection of kittens from feline leukaemia virus infection by maternally-derived antibody | Q40108951 |
| | The immunobiology of the feline leukemia virus | Q40110710 |
| | Excretion of feline leukaemia virus by naturally infected pet cats | Q40119500 |
| | Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses | Q40126719 |
| | Lysis of Feline Lymphoma Cells by Complement-Dependent Antibodies in Feline Leukemia Virus Contact Cats. Correlation of Lysis and Antibodies to Feline Oncornavirus-Associated Cell Membrane Antigen 2 | Q40130074 |
| | The frequency of occurrence of feline leukaemia virus subgroups in cats | Q40135112 |
| | Nucleotide sequences of the envelope genes of two isolates of feline leukemia virus subgroup B. | Q40139033 |
| | Acute Transforming Feline Retroviruses | Q40140343 |
| | Proposal for Naming Host Cell-Derived Inserts in Retrovirus Genomes | Q40144761 |
| | Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus | Q40155346 |
| | Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma | Q40156435 |
| | Differential growth and transmission in cats of feline leukaemia viruses of subgroups A and B | Q40159628 |
| | The specificity of neutralizing antibodies to feline leukaemia viruses | Q40159663 |
| | Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein | Q40161653 |
| | The occurrence of feline leukaemia virus neutralizing antibodies in cats | Q40178544 |
| | Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells | Q40180044 |
| | Feline leukemia virus envelope glycoprotein vaccine: preparation and evaluation of immunizing potency in guinea pig and cat | Q40190802 |
| | Inhibition of human lymphocyte mitogen and antigen response by a 15,000-dalton protein from feline leukemia virus | Q40203210 |
| | Mobility of lymphocyte surface membrane concanavalin A receptors of normal and feline leukemia virus-infected viremic felines | Q40216065 |
| | Hypocomplementemia associated with naturally occurring lymphosarcoma in pet cats | Q40232191 |
| | Pathogenesis of Experimental Feline Leukemia Virus Infection2 | Q40246793 |
| | Incorporation of HLA antigens into the envelope of RNA tumor viruses grown in human cells | Q40251395 |
| | Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection | Q40251427 |
| | Humoral immune response of asymptomatic cats naturally infected with feline leukemia virus. | Q40308302 |
| | Distinctive peripheral lymph node hyperplasia of young cats | Q40806660 |
| | Post-exposure treatment with monoclonal antibodies in a retrovirus system: failure to protect cats against feline leukemia virus infection with virus neutralizing monoclonal antibodies | Q41366606 |
| | Recombinant DNA approaches to feline leukemia virus immunization | Q41367404 |
| P304 | page(s) | 57-96 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Advances in Veterinary Medicine | Q15764502 |
| P1476 | title | Feline leukemia/sarcoma viruses and immunodeficiency | |
| P478 | volume | 32 | |